# Maternal Probiotic Intervention to Improve Gut Health - Trial II - Bangladesh

> **NCT06817031** · PHASE2 · ENROLLING_BY_INVITATION · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 144 (estimated)

## Conditions studied

- Environmental Enteric Dysfunction

## Interventions

- **DRUG:** VE818
- **DRUG:** Placebo
- **DRUG:** Oral Vancomycin

## Key facts

- **NCT ID:** NCT06817031
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-20
- **Primary completion:** 2026-04
- **Final completion:** 2026-10
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06817031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06817031, "Maternal Probiotic Intervention to Improve Gut Health - Trial II - Bangladesh". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06817031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*